Techtonic

SpaceX has captured the attention of media, investors, and the public for years now — interest propelled by the company’s reusable rocket launches, the rise of its Starlink satellite network, and of course, for its founder and CEO Elon Musk. But in its 24-year history, nothing quite compares to this initial public offering. Everyone seems […] More

Again, that doesn’t mean senolytic drugs that target “zombie cells” won’t work. But it feels as if many in the field have moved on. These days, the buzz is all about ✨reprogramming✨. The idea here is to essentially return cells to a young state. It’s based on the Nobel Prize–winning discovery that four genetic factors […] More

SpaceX lifted off on its first day as a public company, immediately jumping to $150 a share after it began trading on the Nasdaq, around 11% higher than the $135 figure at which it officially priced its IPO on Thursday. The stock price reached as high as $176 in midday trading, pushing the company’s market […] More

The doors of the cell Liberles is mapping the vagus information highways. But highways need on-ramps for signals to enter. For years, one of neurobiology’s biggest mysteries was the molecular on-ramp for our sense of touch. Somewhere, something in our bodies was converting physical force into an electrical signal that the nervous system could understand. […] More

The IPO market is back, and it’s not the same companies leading the charge. FAANG had a good run, but a new acronym is taking over: MANGOS — Meta (or Microsoft, depending on who you ask), Anthropic, Nvidia, Google, OpenAI, and SpaceX. Half of that bunch is heading to public markets in the same window, and it’s a stress test for investors, for valuations, and for […] More

The idea is to treat the disease by regenerating healthy nerves in the eye—but the company already hopes to go further. If the treatment can reverse glaucoma, similar treatments could reverse other diseases of aging. Maybe, just maybe, they could reverse aging altogether. The approach relies on “reprogramming” cells to a younger state. It’s one […] More

The House of Representatives has failed to renew the U.S. government’s warrant-less surveillance law before it is due to expire on Friday, all but guaranteeing that it will lapse for the first time, as lawmakers protest the appointment of a controversial Trump ally to oversee U.S. intelligence agencies. The House voted 218-198 on the bill, […] More

I tilted my face up and gave the eye in the sky the finger. It didn’t matter. They already knew where I was. “Let’s go in.” “Wait,” said Gibson, both hands cradling a mug of Mormon tea—a desert plant with tiny orange flowers that isn’t tea at all and doesn’t even taste like it. “You […] More

In India, consumers receive a lot of calls every day, ranging from spam and scams to delivery people and financial service companies trying to contact them. There are apps like Truecaller and the government’s Calling Name Presentation (CNAP) system to identify who is calling, but knowing the name of the caller is often not enough. […] More

Cernak imagines a world where “the patient was always meant to be a frog in the first place, from the beginning to the end.” Now an associate professor at the University of Michigan, he’s worked on all types of creatures, from a Gila monster with a parasite to bald eagles with avian flu. Here’s what […] More

Humanoids aren’t quite ready to replace factory workers, but the industry can’t wait. Faced with labor shortages, manufacturers have shown growing interest in startups that promise faster automation without the usual tradeoffs. That’s the bet behind Theker, an AI robotics startup that aims to go beyond robots trained for a single task. “If you always […] More